Pharming Group N.V.
PHAR · NASDAQ
Bulios Fair Price
$9.52
9.8% downside
Trenutna cena
$10.55
Po podatkih Bulios Fair Price je delnica PHAR trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Pharming Group N.V. is a Dutch biotechnology company that specializes in the development and commercialization of innovative drugs targeting genetically determined diseases and immune disorders. The company is particularly known for its work in producing therapeutic proteins, including medications for the treatment of rare diseases. Pharming is recognized for its research in genetic therapy and recombinant biotechnology, especially concerning the production of medicinal substances aimed at improving the quality of life for patients with severe conditions.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Fabrice Chouraqui
Employees
407
Headquarters
Leiden
Prihajajoči dogodki
Earnings
Upcoming earnings report